Test Price
2,800 AED✅ Home Collection Available
ACTA2 Gene Multisystemic Smooth Muscle Dysfunction Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ACTA2 لمتلازمة خلل العضلات الملساء متعدد الأجهزة بتقنية التسلسل الجيني NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary | ملخص تنفيذي
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection with ISO Certified Cold-Chain Transport and VIP Mobile Phlebotomy.
- ✓ Clinical Guidance: Complimentary Telephonic Post-Test Clinical Interpretation by a DHA-Licensed Neurologist.
- ✓ Insurance: Direct Billing Verification & Pre‑Authorization via WhatsApp +971 54 548 8731.
ضمان الدقة: حساسية تشخيصية بنسبة 99.9% عبر معالجة معتمدة من ISO. خدمة سحب منزلي فاخرة بمستوى المستشفيات مع سلسلة تبريد معتمدة. إرشاد سريري هاتفي بعد الفحص لتفسير النتائج. تحقق من التغطية التأمينية عبر واتساب +971545488731.
Overview: ACTA2 Gene Sequencing in Dubai
This definitive NGS test sequences the entire coding region of the ACTA2 gene to identify pathogenic variants responsible for multisystemic smooth muscle dysfunction syndrome (MSMDS), a hereditary disorder affecting vascular, ocular, and cerebrovascular smooth muscle. It is the gold‑standard for confirming clinical suspicion, guiding surveillance protocols, and enabling family cascade screening.
| Feature | Our ACTA2 NGS Test | Closest Alternative |
|---|---|---|
| Diagnostic Precision | Full‑gene NGS with 99.9% sensitivity | Single‑variant PCR, < 30% mutation coverage |
| Methodology | Next‑Generation Sequencing (Illumina® platform) | Sanger sequencing, limited to known hotspots |
| Turnaround Time | 3–4 Weeks (expedited options available) | 4–6 Weeks or longer |
| Clinical Support | Post‑test DHA neurologist tele‑consultation | Generic lab report without specialist review |
| Price | 2800 AED | Varies (often >3500 AED without interpretation) |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011, Consultant Neurologist) emphasizes: “This test provides high-resolution genotype data, but a positive result must always be correlated with clinical phenotype and imaging findings. Never alter or discontinue prescribed medications without direct medical advice; genetic diagnosis does not replace ongoing specialist care.”
⚠️ Medication Warning: Do not discontinue any prescribed medication without consulting your treating physician.
Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Active bleeding disorder, inability to provide informed consent, acute febrile illness, or recent blood transfusion (within 2 weeks).
- Emergency Red Flags: If you experience sudden, severe headache, vision loss, chest pain radiating to the back, or stroke‑like symptoms, seek immediate emergency care at the nearest hospital. These may indicate aortic aneurysm rupture or moyamoya‑related ischemia.
Patient FAQ & Clinical Guidance
1. What exactly does the ACTA2 genetic test detect?
The ACTA2 Genetic Test sequences the entire ACTA2 gene to detect pathogenic variants causing multisystemic smooth muscle dysfunction syndrome with 99.9% sensitivity. It identifies missense, nonsense, splice‑site, and small insertion/deletion mutations linked to thoracic aortic aneurysm, moyamoya disease, congenital mydriasis, and patent ductus arteriosus. Results guide personalized surveillance and early intervention.
يقوم اختبار ACTA2 بتسلسل الجين بالكامل للكشف عن الطفرات المسببة لمتلازمة خلل العضلات الملساء متعدد الأجهزة بحساسية 99.9%، مما يشمل تمدد الأوعية الدموية الأبهرية ومرض مويامويا وتوسع الحدقة الخلقي والقناة الشريانية السالكة.
2. Who should consider this test – is it only for children or also adults?
This test is indicated for individuals of any age with clinical features suggestive of MSMDS, family history of ACTA2‑related disease, or unexplained thoracic aortic aneurysm/stroke in young adults. With CDS Law 2026, minors require legal guardian consent and mandatory pre‑ genetic counseling. Adults can self‑refer, but a neurologist or clinical geneticist referral optimizes testing appropriateness.
يُنصح بالاختبار لأي شخص تظهر عليه أعراض المتلازمة أو لديه تاريخ عائلي للإصابة، مع ضرورة موافقة الوالدين للقُصّر بموجب قانون المواد الخاضعة للرقابة 2026. يجب استشارة طبيب أعصاب أو اختصاصي وراثة سريري.
3. How long does it take and how will I receive my results confidentially?
Turnaround time is 3 to 4 weeks post sample collection; results are delivered through a secure, encrypted patient portal compliant with UAE PDPL and Federal Decree‑Law No. 41 of 2024 on health data privacy. A DHA‑licensed neurologist will schedule a tele‑consult to walk you through the findings and recommended next steps.
تستغرق النتائج 3-4 أسابيع وتُسلّم عبر بوابة إلكترونية آمنة ومتوافقة مع قانون حماية البيانات الشخصية الإماراتي والمرسوم الاتحادي رقم 41 لسنة 2024، مع استشارة هاتفية من طبيب أعصاب مرخص.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians